Outlook Therapeutics (OTLK) EPS (Diluted) (2016 - 2026)
Powered by 
Analysis
Outlook Therapeutics (OTLK) EPS (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | Outlook Therapeutics | 88.06 Mn | 76.82 Mn | -8,265.00 | -0.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15 |
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -1.50 |
| Dec 31, 2024 | 0.72 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 1.74 |
| Mar 31, 2024 | -8.01 |
| Dec 31, 2023 | -0.86 |
| Sep 30, 2023 | -1.04 |
| Jun 30, 2023 | -1.61 |
| Mar 31, 2023 | -0.52 |
| Dec 31, 2022 | -1.64 |
| Sep 30, 2022 | -1.35 |
| Jun 30, 2022 | -1.59 |
| Mar 31, 2022 | -1.80 |
| Dec 31, 2021 | -1.54 |
| Sep 30, 2021 | -1.76 |